BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2025-09

206 industry Phase 2/3 trial readout(s) and 31 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2025-08 | 2025-10 →

FDA decision events

DateEventStatusCompanyDrugSource
2025-09-03FDA approvalapprovedABBVIE INC ABBVSKYRIZIApproved 2025-09-03: SKYRIZI (BLA761262 SUPPL11)
2025-09-03FDA approvalapprovedPYROS PHARMSVIGAFYDEApproved 2025-09-03: VIGAFYDE (NDA217684 SUPPL2)
2025-09-03FDA approvalapprovedABBVIE INC ABBVSKYRIZIApproved 2025-09-03: SKYRIZI (BLA761105 SUPPL39)
2025-09-09FDA approvalapprovedTHEA PHARMAZOLYMBUSApproved 2025-09-09: ZOLYMBUS (NDA217307 ORIG1)
2025-09-09FDA approvalapprovedJANSSEN BIOTECHINLEXZOApproved 2025-09-09: INLEXZO (NDA219683 ORIG1)
2025-09-10FDA approvalapprovedASTRAZENECA AZNKOSELUGOApproved 2025-09-10: KOSELUGO (NDA213756 SUPPL5)
2025-09-10FDA approvalapprovedASTRAZENECA AZNKOSELUGOApproved 2025-09-10: KOSELUGO (NDA219943 ORIG1)
2025-09-10FDA approvalapprovedEXELIXIS INC EXELCABOMETYXApproved 2025-09-10: CABOMETYX (NDA208692 SUPPL18)
2025-09-12FDA approvalapprovedCORSTASIS THERAPENBUMYSTApproved 2025-09-12: ENBUMYST (NDA219500 ORIG1)
2025-09-15FDA approvalapprovedASTRAZENECA AZNAIRSUPRAApproved 2025-09-15: AIRSUPRA (NDA214070 SUPPL1)
2025-09-16FDA approvalapprovedOWP PHARMSSUBVENITEApproved 2025-09-16: SUBVENITE (NDA218879 ORIG1)
2025-09-16FDA approvalapprovedPFIZER PFEIBRANCEApproved 2025-09-16: IBRANCE (NDA207103 SUPPL23)
2025-09-16FDA approvalapprovedBIOCON BIOLOGICS INCAUKELSO; BOSAYAApproved 2025-09-16: AUKELSO; BOSAYA (BLA761436 ORIG1)
2025-09-16FDA approvalapprovedPFIZER PFEIBRANCEApproved 2025-09-16: IBRANCE (NDA212436 SUPPL11)
2025-09-18FDA approvalapprovedINCYTE CORP INCYOPZELURAApproved 2025-09-18: OPZELURA (NDA215309 SUPPL7)
2025-09-19FDA approvalapprovedJANSSEN BIOTECHTREMFYAApproved 2025-09-19: TREMFYA (BLA761061 SUPPL26)
2025-09-19FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDA QLEXApproved 2025-09-19: KEYTRUDA QLEX (BLA761467 ORIG1)
2025-09-19FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDA QLEXApproved 2025-09-19: KEYTRUDA QLEX (BLA761467 ORIG2)
2025-09-19FDA approvalapprovedSTEALTH BIOTHERAPSFORZINITYApproved 2025-09-19: FORZINITY (NDA215244 ORIG1)
2025-09-22Complete response lettercomplete responseBiogen, Inc. BIIBSpinrazaCRL 2025-09-22: Biogen, Inc. NDA 209531/S-016 (Spinraza (nusinersen) injection)
2025-09-22Complete response lettercomplete responseScholar Rock, Inc. SRRKSRK-015 (apitegromab-mstn) injectionCRL 2025-09-22: Scholar Rock, Inc. BLA 761463 (SRK-015 (apitegromab-mstn) injection)
2025-09-24FDA approvalapprovedMEDRX USABONDLIDOApproved 2025-09-24: BONDLIDO (NDA215029 ORIG1)
2025-09-25FDA approvalapprovedREGENERON PHARMACEUTICALS REGNEVKEEZAApproved 2025-09-25: EVKEEZA (BLA761181 SUPPL2)
2025-09-25FDA approvalapprovedELI LILLY AND CO LLYINLURIYOApproved 2025-09-25: INLURIYO (NDA218881 ORIG1)
2025-09-25FDA approvalapprovedCRINETICSPALSONIFYApproved 2025-09-25: PALSONIFY (NDA219070 ORIG1)
2025-09-26FDA approvalapprovedCARWIN PHARM ASSOCCLOTICApproved 2025-09-26: CLOTIC (NDA217628 ORIG1)
2025-09-26FDA approvalapprovedHIKMA PHARMACEUTICALS USA INCENOBY; XTRENBOApproved 2025-09-26: ENOBY; XTRENBO (BLA761439 ORIG1)
2025-09-26FDA approvalapprovedJANSSEN BIOTECHTREMFYAApproved 2025-09-26: TREMFYA (BLA761061 SUPPL29)
2025-09-26FDA approvalapprovedJANSSEN BIOTECHTREMFYAApproved 2025-09-26: TREMFYA (BLA761061 SUPPL28)
2025-09-30Complete response lettercomplete responseSentynl Therapeutics, Inc.copper histidinateCRL 2025-09-30: Sentynl Therapeutics, Inc. NDA 211241 (copper histidinate)
2025-09-30FDA approvalapprovedNOVARTIS NVSRHAPSIDOApproved 2025-09-30: RHAPSIDO (NDA218436 ORIG1)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2025-09 est.P1/P2Chung Mei Biopharma Co., LtdNCT02994498 Safety and Efficacy of DCB-BO1301 in Advanced MelanomaAdvanced Melanomaunknown33
2025-09 est.P2AphiosNCT03813095 Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid AddictionAddiction; Opioid Dependence; Opioid Withdrawalunknown32
2025-09 est.P3Hinova Pharmaceuticals Inc.NCT03851640 A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).MCRPCrecruiting417
2025-09 est.P2Replimune, Inc. REPLNCT04050436 Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin CancerCutaneous Squamous Cell Carcinoma; Advanced Cutaneous Squamous Cell Carcinoma; Metastatic Cutaneous active not recruiting231
2025-09 est.P1/P2Aegle TherapeuticsNCT04173650 MSC EVs in Dystrophic Epidermolysis BullosaDystrophic Epidermolysis Bullosarecruiting8
2025-09 est.P1/P2Kahr MedicalNCT04440735 A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid TumorsAdvanced Solid Tumor; Non Small Cell Lung Cancer; Colorectal Canceractive not recruiting125
2025-09 est.P1/P2DynacureNCT04743557 Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear MyopathiesCentronuclear Myopathywithdrawn
2025-09 est.P24SC AGNCT04874831 Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)Merkel Cell Carcinomawithdrawn
2025-09 est.P1/P2AkesoNCT04900350 A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic SyndromeMyelodysplastic Syndromeactive not recruiting136
2025-09 est.P1/P2EutilexNCT04903873 A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsSolid Tumor; Renal Cell Cancer Metastatic; Non-Small Cell Lung Cancer; Renal Cell Carcinoma; Prostatunknown110
2025-09 est.P2Kibow PharmaNCT04913272 Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IVChronic Kidney Disease stage4suspended630
2025-09 est.P1/P2AkesoNCT04980885 A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid LeukemiaAcute Myeloid Leukemiaactive not recruiting68
2025-09 est.P1/P2Xuanzhu Biopharmaceutical Co., Ltd.NCT04996121 A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid TumorsLocally Advanced or Metastatic Solid Tumors; Locally Advanced or Metastatic Non-small Cell Lung Cancrecruiting360
2025-09 est.P3Bausch Health Americas, Inc.NCT05071716 Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisHepatic Encephalopathyactive not recruiting524
2025-09 est.P1/P2Ascentage Pharma Group Inc. AAPGNCT05186012 APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin LymphomaNHL, Adultunknown51
2025-09 est.P2Partner Therapeutics, Inc.NCT05284214 Sargramostim With Ipilimumab Containing Therapy in Patients With Solid TumorsSolid Tumor; Solid Tumor, Adultwithdrawn
2025-09 est.P1/P2SCG Cell Therapy Pte. Ltd.NCT05417932 A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular CarcinomaHepatitis B Virus Related Hepatocellular Carcinoma; Hepatocellular Carcinoma Recurrentrecruiting46
2025-09 est.P2Qu Biologics Inc.NCT05421325 Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older AdultsImmune Deficiencyrecruiting72
2025-09 est.P1/P2Editas Medicine, Inc. EDITNCT05444894 EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)Transfusion Dependent Beta Thalassemia; Hemoglobinopathies; Thalassemia Major; Thalassemia Intermediactive not recruiting9
2025-09 est.P3EMSNCT05542173 Efficacy and Safety of BALI Association in the Treatment of Aphthous UlcerationsAphthous Stomatitisunknown232
2025-09 est.P2COMPASS Pathways CMPSNCT05733546 A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in ParticMajor Depressive Disorderactive not recruiting102
2025-09 est.P1/P2BiocadNCT05747261 Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in ChilSpinal Muscular Atrophy (SMA)recruiting40
2025-09 est.P3Areteia TherapeuticsNCT05748600 A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic AsthmaEosinophilic Asthma; Asthma; Eosinophilic; Asthma Attackactive not recruiting600
2025-09 est.P3Polpharma Biologics S.A.NCT05771155 Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®Ulcerative Colitisunknown750
2025-09 est.P2George Medicines PTY LimitedNCT05833958 Polypill Versus Metformin in New Onset Type 2 DiabetesType 2 Diabeteswithdrawn
2025-09 est.P3Recardio, Inc.NCT05881382 Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial InfarctionST Elevation Myocardial Infarctionunknown4100
2025-09 est.P3Natural Wellness EgyptNCT06140485 A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes MellitusDiabetes Mellitus, Type 2unknown400
2025-09 est.P3Daewoong Pharmaceutical Co. LTD.NCT06141980 Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes MellitusT2DM (Type 2 Diabetes Mellitus)unknown134
2025-09 est.P2Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)NCT06233903 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous SystemNeuroblastoma; Pheochromocytoma; Paragangliomawithdrawn
2025-09 est.P3Addpharma Inc.NCT06441630 A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227BEssential Hypertensionrecruiting251
2025-09 est.P1/P2Nimble Diagnostics S.L.NCT06968858 Pilot Study of the α Prototype NIMBLE System: Feasibility, Safety, and Initial Performance in Non-Invasive Detection of Coronary In-Stent RestenosisIn-stent Restenosis; Stent Fracture; Stent Complicationrecruiting30
2025-09-01P3Alector Inc. ALECNCT04374136 A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)Frontotemporal Dementiaterminated119
2025-09-01P1/P2Bristol-Myers Squibb BMYNCT05134948 A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid TumorsAdvanced Solid Tumorscompleted24
2025-09-01P2Intercept PharmaceuticalsNCT05239468 Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBCPrimary Biliary Cholangitiscompleted72
2025-09-01 est.P1/P2RemeGen Co., Ltd.NCT05821933 RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLCNSCLCunknown106
2025-09-01P2MAXVAX Biotechnology Limited Liability CompanyNCT05856084 Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and AboveHerpes Zostercompleted924
2025-09-01P3Meiji Seika Pharma Co., Ltd.NCT05905055 P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to CarbapenemComplicated Urinary Tract Infection; Acute Pyelonephritis; Hospital-acquired Bacterial Pneumonia; Vecompleted126
2025-09-01P3Alector Inc. ALECNCT06111014 Continuation Study for LatozinemabNeurodegenerative Diseasesterminated17
2025-09-01P2GemVax & KaelNCT06235775 Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011Progressive Supranuclear Palsycompleted67
2025-09-01 est.P3Chengdu CoenBiotech Co., LtdNCT06241755 Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle InNon-Muscle Invasive Bladder Cancerunknown412
2025-09-01 est.P2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06246565 A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)Coughunknown276
2025-09-01 est.P2Neuroventi Inc.NCT06951854 Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum DisorderAutism Spectrum Disorder (ASDrecruiting105
2025-09-01 est.P3Shanghai Cingularbio Co. LtdNCT06968221 Bovine Reinforcement in Stomach, Colorectal and Lung OperationRectal Cancer Stage III; Lung Cancer Stage IIIrecruiting172
2025-09-01P2Bharat Biotech International LimitedNCT06997367 Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)Tuberculosis (TB)active not recruiting164
2025-09-02P2/P3Tetra Discovery PartnersNCT05163808 A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X SyndromeFragile X Syndromecompleted163
2025-09-02P3AbbVie ABBVNCT05652205 A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional ConstipationFunctional Constipation (FC); Chronic Idiopathic Constipation (CIC)completed123
2025-09-02P2Boehringer IngelheimNCT06139328 IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart AttackMyocardial Infarctionterminated160
2025-09-02P2Cardurion Pharmaceuticals, Inc.NCT06215586 Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)Heart Failure; Heart Failure Preserved Ejection Fraction; Cardiovascular Diseases; Heart Diseasescompleted303
2025-09-02P3GlaxoSmithKlineNCT06261957 A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in PAsthmacompleted471
2025-09-02P2Boehringer IngelheimNCT06360094 A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis; Progressive Pulmonary Fibrosisterminated85
2025-09-02P3MoonLake Immunotherapeutics AG MLTXNCT06411899 A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppuraHidradenitis Suppurativacompleted422
2025-09-03P3Faraday Pharmaceuticals, Inc. CPPKFNCT04837001 Evaluation in STEMI Patients Using FDY-5301Acute Myocardial Infarction; STEMI; Percutaneous Coronary Revascularizationcompleted2351
2025-09-03P2Forma Therapeutics, Inc.NCT04987489 A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseSickle Cell Disease; Thalassemiacompleted53
2025-09-03P2Hoffmann-La RocheNCT05419375 Screening Study for Participants With Malignant TumorsSolid Tumorscompleted470
2025-09-03P2Merck Sharp & Dohme LLC MRKNCT05508867 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical HodgHodgkin Lymphomacompleted203
2025-09-03P3Biofrontera Inc. BFRINCT05662202 Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities andActinic Keratosescompleted172
2025-09-04P3Apellis Pharmaceuticals, Inc.NCT03531255 Pegcetacoplan Long Term Safety and Efficacy Extension StudyPNHcompleted137
2025-09-04P1/P2Hoffmann-La RocheNCT05251948 An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction CarcinomaGastric and Gastroesophageal Junction Carcinomaterminated40
2025-09-04P2Janssen Research & Development, LLCNCT05379634 A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory MyopathiesMyositiscompleted36
2025-09-04P3Hoffmann-La RocheNCT05627557 A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic SyndromeChildhood Idiopathic Nephrotic Syndromecompleted85
2025-09-04P3Vertex Pharmaceuticals Incorporated VERXNCT05882357 Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of AgeCystic Fibrosiscompleted67
2025-09-04P2Enyo PharmaNCT06425055 Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)Alport Syndromecompleted26
2025-09-05P1/P2Elevar TherapeuticsNCT04526106 REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid TumorsFGFR2 Amplification; FGFR2 Gene Mutation; FGFR2 Gene Fusion/Rearrangement; FGFR2 Gene Translocation;completed490
2025-09-05P3Hoffmann-La RocheNCT04586023 Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Relapsing Multiple Sclerosisactive not recruiting751
2025-09-05P1/P2Arcus Biosciences, Inc. RCUSNCT04660812 An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.Metastatic Colorectal Cancercompleted227
2025-09-05P3Apellis Pharmaceuticals, Inc.NCT04770545 An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDGeographic Atrophy Secondary to Age-related Macular Degenerationcompleted792
2025-09-05P2Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USANCT04945460 A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)Hypertension, Pulmonarycompleted165
2025-09-05P3Seagen, a wholly owned subsidiary of PfizerNCT05132582 A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerHER2 Positive Breast Canceractive not recruiting654
2025-09-05P2Avidity Biosciences, Inc.NCT05479981 Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) PatientsDM1; Muscular Dystrophies; Myotonic Dystrophy; Myotonic Dystrophy 1; Myotonic Disorders; Muscular Dicompleted37
2025-09-05P1/P2Arrowhead Pharmaceuticals ARWRNCT05537025 Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosiscompleted105
2025-09-05P1/P2Pfizer PFENCT06206837 A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Breast Canceractive not recruiting71
2025-09-05P3Dong-A ST Co., Ltd.NCT06290349 Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Type 2 Diabetesactive not recruiting174
2025-09-06P2Cytoki PharmaNCT06611930 CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 DiabetesType 2 Diabetes Mellitus (T2DM); Obesity and Overweightterminated90
2025-09-06P3HALEON HLNNCT07140341 A Clinical Study to Assess the Effectiveness of ENO Lime in Participants With Ajeerna Vyadhi (Acidity, Acid Indigestion, Indigestion, and Associated Nausea)Indigestion Acid; Indigestion; Nauseacompleted40
2025-09-07 est.P1/P2Biotheus Inc.NCT05862831 Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid TumorsAdvanced Solid Tumorsunknown285
2025-09-08 est.P3Azidus BrasilNCT06097780 Efficacy and Safety of NestaCell® in Huntington's DiseaseHuntington Diseaseunknown120
2025-09-08P2Blueprint Medicines CorporationNCT06922448 Study of BLU-808 in Allergic RhinoconjunctivitisAllergic Rhinoconjunctivitiscompleted21
2025-09-08P2GenfitNCT06987968 A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic EncephalopathyHepatic Encephalopathy; Acute on Chronic Liver Failure (ACLF); Decompensated Cirrhosisterminated3
2025-09-09P2Hipra Scientific, S.L.UNCT06234956 Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.SARS CoV 2 Infectioncompleted242
2025-09-09P3Novo Nordisk A/S NVONCT06323161 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal IType 2 Diabetescompleted274
2025-09-09P3Famy Life Sciences, a Viatris CompanyNCT06400511 A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic OintmentBlepharitisterminated477
2025-09-10P1/P2Arrowhead Pharmaceuticals ARWRNCT05083364 Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal DiseaseC3 Glomerulopathy; IgA Nephropathycompleted62
2025-09-10P3Novartis Pharmaceuticals NVSNCT05666804 Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal VasculopMacular Polypoidal Choroidal Vasculopathy (PCV)completed148
2025-09-10P3Novartis Pharmaceuticals NVSNCT05767034 Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica Polymyalgia Rheumaticacompleted381
2025-09-10P1/P2Inmune Bio, Inc. INMBNCT06056791 Study of INKmune in Patients With mCRPC (CaRe Prostate)Cancer; Metastatic Castration-resistant Prostate Cancer; mCRPCcompleted12
2025-09-10P2Zomagen Biosciences Ltd.NCT06771115 Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in ObesityObesitycompleted175
2025-09-11P2Eledon Pharmaceuticals ELDNNCT05983770 Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationKidney Transplant Rejectioncompleted127
2025-09-11P2TWi Biotechnology, Inc.NCT06285916 A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum DepressionDepression, Postpartum; Postpartum Depression; Post-partum Depression; Postnatal Depression; Post-Nacompleted93
2025-09-11P3UroGen Pharma Ltd. URGNNCT06331299 A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder CancerBladder Cancer; Urothelial Carcinoma; Urothelial Carcinoma Bladdercompleted99
2025-09-11P2Guard Therapeutics ABNCT06475274 A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac SurgeryKidney Injury Following Open-Chest Cardiac Surgerycompleted170
2025-09-11P3Bionomics LimitedNCT06510504 Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1Social Anxiety Disordercompleted370
2025-09-11P3Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.NCT06552520 To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic DermatitisAtopic Dermatitiscompleted500
2025-09-11P2Orion Corporation, Orion Pharma ORNNCT06956495 Efficacy and Tolerability of Tasipimidine in Sleepless PatientsInsomniacompleted190
2025-09-12P2Zydus Therapeutics Inc.NCT05011305 Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With FibrosisNonalcoholic Steatohepatitis; Fibrosiscompleted189
2025-09-12P2Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.NCT07052097 Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic RhinitisSeasonal Allergic Rhinitiscompleted136
2025-09-14P3GlaxoSmithKlineNCT04718389 A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic PhenotypeAsthmacompleted1717
2025-09-15P2Eidos Therapeutics, a BridgeBio companyNCT03536767 Open-Label Study of AG10 in Patients With CardiomyopathyAmyloid Cardiomyopathyterminated47
2025-09-15P3Novo Nordisk A/S NVONCT04777409 A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)Early Alzheimer´s Diseasecompleted1840
2025-09-15P3Hoffmann-La RocheNCT04963296 A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus ErythematosusSystemic Lupus Erythematosusactive not recruiting303
2025-09-15P2Silver Creek PharmaceuticalsNCT05585606 Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic StrokeAcute Ischemic Stroke (AIS)completed120
2025-09-15P3Cali Pharmaceuticals LLCNCT05813847 Herniorrhaphy for Postoperative PainHernia, Inguinal; Post Operative Paincompleted518
2025-09-15P2Ono Pharmaceutical Co., Ltd.NCT05923866 A Phase 2 Study of ONO-2808 in Patients With Multiple System AtrophyMultiple System Atrophy (MSA)active not recruiting92
2025-09-15P2LigaChem Biosciences, Inc.NCT06004037 Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus ComplexNontuberculous Mycobacterium Infection; Mycobacterium Abscessus Infectioncompleted24
2025-09-15P3Eli Lilly and Company LLYNCT06109311 A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/orType 2 Diabetescompleted546
2025-09-15 est.P2Bright Minds Biosciences Pty Ltd DRUGNCT06401538 BMB-101 in Absence Epilepsy and DEEAbsence Epilepsy; Jeavons Syndrome; Dravet Syndrome; Lennox Gastaut Syndromerecruiting20
2025-09-16P3Novo Nordisk A/S NVONCT04777396 A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)Early Alzheimer's Diseasecompleted1840
2025-09-16P3ViiV HealthcareNCT05917509 A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months fHIV Infectionscompleted171
2025-09-16P2Sanofi SNYNCT06280391 A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis BronchiectasisBronchiectasiscompleted314
2025-09-16P3R-PharmNCT07435324 A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinomacompleted161
2025-09-17P3Hoffmann-La RocheNCT04544449 A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple SclerosisMultiple Sclerosis, Primary Progressiveactive not recruiting985
2025-09-17P3Novartis Pharmaceuticals NVSNCT06042478 Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU PatienChronic Spontaneous Urticariaactive not recruiting470
2025-09-17P3Innovent Biologics (Suzhou) Co. Ltd.NCT06184568 A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and ObesityType 2 Diabetes; Obesitycompleted349
2025-09-17P2Regeneron Pharmaceuticals REGNNCT06237309 REGN5381 in Adult Participants With Heart Failure With Reduced Ejection FractionHeart Failureterminated89
2025-09-18P3Hoffmann-La RocheNCT03194893 A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive CancerNeoplasmscompleted50
2025-09-18P2GlaxoSmithKlineNCT05412030 A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsPneumonia, Bacterial; Pneumococcal Infections; Pneumonia, Pneumococcalcompleted388
2025-09-18P2Engrail Therapeutics INCNCT05749055 ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety DisorderGeneralized Anxiety Disordercompleted252
2025-09-18P3Sanofi Pasteur, a Sanofi Company SNYNCT06397768 Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersRSV Immunizationterminated2226
2025-09-19P3BayerNCT04015180 Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090Retinopathy of Prematurity (ROP)completed100
2025-09-19P3OctapharmaNCT04502030 Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in PatientsChronic Lymphocytic Leukemia; Hypogammaglobulinemiacompleted247
2025-09-19P3Alexion Pharmaceuticals, Inc.NCT04543591 Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantThrombotic Microangiopathycompleted148
2025-09-19P3Novartis Pharmaceuticals NVSNCT04578834 Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsIgA Nephropathycompleted517
2025-09-19P2Cogent Biosciences, Inc. COGTNCT04996875 (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisAdvanced Systemic Mastocytosis (AdvSM); SM With an Associated Hematologic Neoplasm (SM-AHN); Mast Cerecruiting140
2025-09-19 est.P1/P2Shanghai Huaota Biopharmaceutical Co., Ltd.NCT06056323 A Study of HB0045 Injection in Patients With Advanced Solid TumorsSolid Tumor, Adultunknown71
2025-09-19P2Novo Nordisk A/S NVONCT06326047 A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 DiabetesDiabetes Mellitus, Type 2completed299
2025-09-19P3Alumis Inc ALMSNCT06586112 A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque PsoriasisPlaque Psoriasiscompleted912
2025-09-19P3Jiangsu HengRui Medicine Co., Ltd.NCT06881264 A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesAdult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugscompleted401
2025-09-20P3Pfizer PFENCT05512819 A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and TaiwanPneumococcal Diseasecompleted541
2025-09-20P1/P2InxMed (Shanghai) Co., Ltd.NCT05994131 IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLCNSCLCactive not recruiting110
2025-09-22P2BioAtla, Inc. BCABNCT05271604 A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckHead and Neck Cancer; Squamous Cell Carcinoma of Head and Neck; Recurrent Squamous Cell Carcinoma ofcompleted42
2025-09-22P2Arrowhead Pharmaceuticals ARWRNCT05413135 Study of ARO-APOC3 in Adults With DyslipidemiaDyslipidemiascompleted418
2025-09-22P2AbbVie ABBVNCT06032546 A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency VHuman Immuno-deficiency Virus (HIV) Diseaseterminated163
2025-09-22 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06222671 A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)Axial Spondyloarthritisrecruiting180
2025-09-22P3Teikoku Seiyaku Co., Ltd.NCT06871046 Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With ContusionsContusionscompleted221
2025-09-22P2ShionogiNCT06928051 A Study of S-892216 in Participants With COVID-19COVID-19completed282
2025-09-23P3AbbVie ABBVNCT04161885 A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) inAcute Myeloid Leukemia (AML); Cancerterminated465
2025-09-23P1/P2Sunshine Lake Pharma Co., Ltd. SBFMNCT05451602 HEC169096 in Participants With Advanced Solid TumorsAdvanced Solid Tumorterminated24
2025-09-23P1/P2Pfizer PFENCT05703607 A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy AdultsShingles; Herpes Zoster Infection; Humanterminated484
2025-09-23P2GlaxoSmithKlineNCT06104319 Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASHNon-alcoholic Fatty Liver Diseasecompleted61
2025-09-23P3Innovent Biologics (Suzhou) Co. Ltd.NCT06126783 A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye DiseaseThyroid Eye Disease, TEDcompleted91
2025-09-23P2Transcend TherapeuticsNCT06215261 An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSDPost Traumatic Stress Disordercompleted62
2025-09-23P3Alumis Inc ALMSNCT06588738 A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001Plaque Psoriasiscompleted862
2025-09-23P2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06886126 Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes MellitusObesityrecruiting240
2025-09-23P3Incepta Pharmaceuticals LtdNCT07025681 PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag).Healthycompleted56
2025-09-23P3Nxera Pharma Korea Co., Ltd.NCT07028697 A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia DisorderInsomnia Disordercompleted164
2025-09-24P1/P2Merck Sharp & Dohme LLC MRKNCT04303169 Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma WhoMelanomacompleted146
2025-09-24 est.P2/P3Shanghai Henlius BiotechNCT04547166 A Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic ColMetastatic Colorectal Cancerrecruiting568
2025-09-24P3Takeda TAKNCT05163314 A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut SyndromeDravet Syndrome (DS); Lennox Gastaut Syndrome (LGS)terminated352
2025-09-24P3Pfizer PFENCT05689164 A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.Duchenne Muscular Dystrophyterminated7
2025-09-24 est.P2Shanghai Kechow Pharma, Inc.NCT05900219 Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical StudyNon-small-cell Lung Cancerunknown75
2025-09-24P2Novo Nordisk A/S NVONCT06131372 A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSemaChronic Kidney Disease; Type 2 Diabetes; Obesitycompleted626
2025-09-24P2Sanofi SNYNCT06444451 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia AreataAlopecia Areataterminated166
2025-09-24P2Minghui Pharmaceutical (Hangzhou) LtdNCT07181187 Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental VitiligoVitiligocompleted156
2025-09-25P2Boehringer IngelheimNCT05512377 Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or BladderPancreatic Neoplasms; Solid Tumors; Biliary Tract Cancer; Lung Neoplasms; Bladder Cancercompleted99
2025-09-25P3Cali Pharmaceuticals LLCNCT05831449 CPL-01 in the Management of Postoperative Pain After BunionectomyBunion; Post-operative Paincompleted616
2025-09-25P1/P2Chongqing Precision Biotech Co., LtdNCT06006403 Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell NeoplasmAcute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Relapse Leukemia; Refrcompleted5
2025-09-25P3Eli Lilly and Company LLYNCT06280716 A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic DermatitisAtopic Dermatitiscompleted301
2025-09-25P2ModernaTX, Inc.NCT06508320 A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SInfluenza; SARS-CoV-2completed931
2025-09-25P2Joincare Pharmaceutical Group Industry Co., LtdNCT07450482 Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPDCOPD (Chronic Obstructive Pulmonary Disease); COPDcompleted42
2025-09-25P3Taejoon Pharmaceutical Co., Ltd.NCT07723716 Evaluate the Efficacy and Safety of CTO0307 in Adults With PresbyopiaPresbyopiacompleted167
2025-09-26P1/P2Epizyme, Inc.NCT02875548 A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyDiffuse Large B-cell Lymphoma (DLBCL); Follicular Lymphoma (FL); Synovial Sarcoma; Epithelioid Sarcoterminated58
2025-09-26P2Aravax Pty LtdNCT05621317 A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut AllergyPeanut Allergy; Peanut Hypersensitivity; Peanut-Induced Anaphylaxis; Immune System Diseasesactive not recruiting95
2025-09-26P2/P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05729373 A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety DisorderGeneralized Anxiety Disordercompleted434
2025-09-26P3Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06173284 Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic DermatitisDermatitis, Atopiccompleted519
2025-09-26P3Eli Lilly and Company LLYNCT06192108 A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminType 2 Diabetescompleted962
2025-09-26P2Rapport Therapeutics Inc. RAPPNCT06377930 Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal EpilepsyFocal Onset Seizurescompleted30
2025-09-26P3Laboratorios Silanes S.A. de C.V.NCT06863662 Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle SpasmAcute Low-back Pain; Muscle Spasm; Back Paincompleted136
2025-09-29P2BayerNCT02576431 A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsSolid Tumors Harboring NTRK Fusioncompleted215
2025-09-29P2/P3Gilead Sciences GILDNCT05502341 Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)HIV-1-infectionactive not recruiting689
2025-09-29P2Combangio, IncNCT05727878 Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCEDPersistent Corneal Epithelial Defectterminated103
2025-09-29P2Indivior Inc.NCT06384157 Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use DisorderOpioid Use Disordercompleted300
2025-09-29P3Shanghai Hengrui Pharmaceutical Co., Ltd.NCT06434961 The Trial of SHR6508 in Secondary HyperparathyroidismSecondary Hyperparathyroidismcompleted498
2025-09-29P3Achieve Life Sciences QUITNCT06435221 Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersSmoking Cessation; Vaping Cessationcompleted479
2025-09-29P2Shandong Suncadia Medicine Co., Ltd.NCT06816264 A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsTreatment of Lipoprotein Disordercompleted120
2025-09-30 est.P1/P2Healeon Medical IncNCT02952131 Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel DiseaseInflammatory Bowel Diseasessuspended100
2025-09-30 est.P2/P3Alloksys Life Sciences B.V.NCT03050476 Preventing Systemic Inflammation After Cardiac Surgery With Alkaline PhosphataseSystemic Inflammation; Cardiopulmonary-bypassunknown1250
2025-09-30P3CelgeneNCT03915769 To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisColitis, Ulcerativecompleted198
2025-09-30 est.P2Hoffmann-La RocheNCT04267237 A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in PNon-small Cell Lung Cancer (NSCLC)withdrawn
2025-09-30 est.P3EMSNCT04666714 Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic PainNeuropathic Painrecruiting136
2025-09-30P2Inhibrx Biosciences, Inc INBXNCT04950075 Study of INBRX-109 in Conventional ChondrosarcomaConventional Chondrosarcomaactive not recruiting206
2025-09-30 est.P1/P2RemeGen Co., Ltd.NCT05205850 A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid TumorsAdvanced Solid Tumorrecruiting135
2025-09-30P3Cogent Biosciences, Inc. COGTNCT05208047 (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsAdvanced Gastrointestinal Stromal Tumors; Metastatic Cancerrecruiting482
2025-09-30P2GPCR Therapeutics, Inc.NCT05561751 Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple MyelMultiple Myelomacompleted30
2025-09-30P2USWM CT, LLCNCT05601752 ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)Ovarian Cancerterminated21
2025-09-30 est.P3Abeona Therapeutics, Inc ABEONCT05725018 A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated PatientsEpidermolysis Bullosa; Recessive Dystrophic Epidermolysis Bullosa; RDEBactive not recruiting12
2025-09-30 est.P1/P2Biocity Biopharmaceutics Co., Ltd.NCT05731518 SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)Small Cell Lung Cancerunknown67
2025-09-30 est.P2Abbisko Therapeutics Co, LtdNCT05775874 A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCUrothelial Carcinomaunknown80
2025-09-30 est.P2Cardior Pharmaceuticals GmbHNCT05953831 Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac HypertrophyHeart Failure With Preserved Ejection Fractionwithdrawn
2025-09-30P2Insmed Incorporated INSMNCT06013241 A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)Chronic Rhinosinusitis Without Nasal Polypscompleted288
2025-09-30P2Eli Lilly and Company LLYNCT06046729 A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativacompleted352
2025-09-30P2/P3Amylyx Pharmaceuticals Inc. AMLXNCT06122662 AMX0035 and Progressive Supranuclear PalsyProgressive Supranuclear Palsy; PSP; Neurodegenerative Diseases; Atypical Parkinsonismcompleted139
2025-09-30 est.P1/P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT06175351 Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)active not recruiting80
2025-09-30P2NeuroSense Therapeutics Ltd. NRSNNCT06185543 A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrAlzheimer Diseaseterminated8
2025-09-30P2BioAegis Therapeutics Inc.NCT06216366 Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA DiversDecompression Sicknesscompleted36
2025-09-30P1/P2TransCode Therapeutics RNAZNCT06260774 Study of TTX-MC138 in Subjects With Advanced Solid TumorsAdvanced Solid Tumoractive not recruiting16
2025-09-30P2GRI Bio Operations, Inc.NCT06331624 Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPFIdiopathic Pulmonary Fibrosis; IPFcompleted35
2025-09-30P2Inflammx Therapeutics IncNCT06437223 Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)Long COVIDcompleted16
2025-09-30 est.P3Biolab Sanus FarmaceuticaNCT06564883 Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal WomenVaginismus; Vaginal Atrophy; Menopauseunknown45
2025-09-30P2Invirsa, Inc.NCT06599684 Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyNon-center Involved Diabetic Macular Edema; Non-center Involved Diabetic Macular Edema Associated Wicompleted19
2025-09-30P2Zealand Pharma ZEAL.CONCT06662539 Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbiditiesObesitycompleted493
2025-09-30P2HiDO TechnologiesNCT06691256 Preventing Medication Mismanagement in People Living With Dementia Through Automated Medication Dispensing With Facial Recognition and Video ObservationAlzheimer Disease; Dementia; Medication Adherence; Type 2 Diabetes Mellitus (T2DM)completed50
2025-09-30 est.P2CNBG-Virogin Biotech (Shanghai) Ltd.NCT06746480 Clinical Study of VG161 in Advanced Intrahepatic CholangiocarcinomaAdvanced Intrahepatic Cholangiocarcinomarecruiting33
2025-09-30 est.P2/P3AVVA Pharmaceuticals Ltd.NCT06835361 Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/VulvovaginitisCandidal Vulvovaginitis (ICD-10 Code: B37.3); Vulvovaginal Candidiasis (VVC)recruiting264
2025-09-30P3Pfizer PFENCT06890416 A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in AdultsRespiratory Syncytial Virus (RSV)completed526
2025-09-30P2Lilac Therapeutics, Inc.NCT06932146 A Phase 2a Study of LLX-424 in Patients With a History of Kidney StonesKidney Stonescompleted51
2025-09-30 est.P2Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.NCT06948357 Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia PatientsPresbyopiarecruiting119
2025-09-30 est.P1/P2Shanghai Huaota Biopharmaceutical Co., Ltd.NCT06992687 A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid TumorsSolid Tumorsenrolling by invitation30

← 2025-08 | 2025-10 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.